Anna Berkenblit's Insider Trades & SAST Disclosures
Anna Berkenblit's most recent trade in Surrozen Inc was a trade of 1,333 Option (right to buy) done . Disclosure was reported to the exchange on June 5, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Anna Berkenblit.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Surrozen Inc | Anna Berkenblit | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 1,333 | 1,333 | - | - | Option (right to buy) | |
| Immunogen, Inc. | Anna Berkenblit | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 4.05 per share. | 30 Jun 2023 | 3,264 | 113,935 (0%) | 0% | 4.0 | 13,219 | Common Stock |
| Surrozen Inc | Anna Berkenblit | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 20,000 | 20,000 | - | - | Option (right to buy) | |
| Immunogen, Inc. | Anna Berkenblit | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 256,300 | 256,300 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Anna Berkenblit | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 63,400 | 63,400 | - | - | Restricted Stock Unit | |
| Immunogen, Inc. | Anna Berkenblit | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 42,700 | 42,700 | - | - | Restricted Stock Unit | |
| Immunogen, Inc. | Anna Berkenblit | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 3.92 per share. | 30 Dec 2022 | 436 | 110,671 (0%) | 0% | 3.9 | 1,709 | Common Stock |
| Immunogen, Inc. | Anna Berkenblit | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 3.82 per share. | 30 Jun 2022 | 3,073 | 110,235 (0%) | 0% | 3.8 | 11,754 | Common Stock |
| Surrozen Inc | Anna Berkenblit | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 20,000 | 20,000 | - | - | Option (right to buy) | |
| Immunogen, Inc. | Anna Berkenblit | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 222,300 | 333,450 | - | - | Stock Option (Right to Buy) | |
| Immunogen, Inc. | Anna Berkenblit | SVP & CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 111,150 | 111,150 | - | - | Stock Option (Right to Buy) | |
| Immunogen, Inc. | Anna Berkenblit | SVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 311,700 | 311,700 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Anna Berkenblit | SVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 5.52 per share. | 30 Jun 2021 | 2,062 | 105,401 (0%) | 0% | 5.5 | 11,382 | Common Stock |
| Immunogen, Inc. | Anna Berkenblit | SVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 282,019 | 282,019 | - | - | Common Stock (right to buy) | |
| Immunogen, Inc. | Anna Berkenblit | VP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 3.91 per share. | 30 Jun 2020 | 3,047 | 101,136 (0%) | 0% | 3.9 | 11,914 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges